The role of IgE in asthma

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 5, 1998, Pages 104-109

  Yssel, H ^a   Abbal, C ^a   Pene J ^a   Bousquet, J ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; B7 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4;

ASTHMA; B LYMPHOCYTE DIFFERENTIATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

EID: 0031735654     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.028s5104.x     Document Type: Conference Paper

References (71)

1. Bousquet J, Yssel H, Vignola M, Chanez P. New developments in the immunology of asthma with a focus on mechanisms and treatment. Curr Opin Pulmonary Med 1997; 3:42-50.
2. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990; 323:502-7.
3. Peat J, Tovey E, Gray E, Mellis C, Woolcock A. Asthma severity and morbidity in a population sample of Sydney schoolchildren. Part II-Importance of house dust mite allergens. Aust NZ J Med 1994; 24:270-6.
4. Peat JK, Tovey E, Toelle BG et al. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Grit Care Med 1996; 153:141-6.
5. Frischer T, Meinert R, Karmaus W, Urbanek R, Kuehr J. Relationship between atopy and frequent bronchial response to exercise in school children. Pediatr Pulmonol 1994; 17:320-5.
6. Platts-Mills TA, Thomas WR, Aalberse RC, Vervloet D, Champman MD. Dust mite allergens and asthma: report of a second international workshop. J Allergy Clin Immunol 1992; 89:1046-60.
7. Lau S, Falkenhorst G, Weber A et al. High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. J Allergy Clin Immunol 1989; 84:718-25.
8. Vervloet D, Charpin D, Haddi E et al. Medication requirements and house dust mite exposure in mite-sensitive asthmatics. Allergy 1991; 46:554-8.
9. Charpin D, Birnbaum J, Haddi E et al. Altitude and allergy to house-dust mites. A paradigm of the influence of environmental exposure on allergic sensitization. Am Rev Respir Dis 1991; 143:983-6.
10. Turner KJ, Stewart GA, Woolcock AJ, Green W, Alpers MP. Relationship between mite densities and the prevalence of asthma: comparative studies in two populations in the Eastern Highlands of Papua New Guinea. Clin Allergy 1988; 18:331-40.
11. Korsgaard J, Iversen M. Epidemiology of house dust mite allergy. Allergy 1991; 46 (Suppl. 11):14-8.
12. Peat J, Tovey E, Mellis C, Leeder S, Woolcock A. Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1973; 23:812-20.
13. Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample:data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol 1992; 90:579-88.
14. Gupta S, Jain S, Chaudhry S, Agarwal MK. Role of insects as inhalant allergens in bronchial asthma with special reference to the clinical characteristics of patients. Clin Exp Allergy 1990; 20:5 19-24.
15. Kang BC, Wu CW, Johnson J. Characteristics and diagnosis of cockroach-sensitive bronchial asthma. Ann Allergy 1992; 68:237-44.
16. Charpin D, Hughes B, Mallea M, Sutra JP, Balansard G, Vervloet D. Seasonal allergic symptoms and their relation to pollen exposure in south-east France. Clin Exp Allergy 1993; 23:435-9.
17. Onorato J, Merland N, Terrai C, Michel FB, Bousquet J. Placebo-controlled double-blind food challenge in asthma. J Allergy Clin Immunol 1986; 78:1139-46.
18. Pollart SM, Chapman MD, Fiocco GP, Rose G, Platts-Mills TA. Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J Allergy Clin Immunol 1989; 83:875-82.
19. Reid MJ, Moss RB, Hsu YP, Kwasnicki JM, Commerford TM, Nelson BL. Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. J Allergy Clin Immunol 1986; 78:590-600.
20. Celenza A, Fothergill J, Kupek E, Shaw RJ. Thunderstorm associated asthma: a detailed analysis of environmental factors. Br Med J 1996; 312:604-7.
21. Knox RB. Grass pollen, thunderstorms and asthma. Clin Exp Allergy 1993; 23:354-9.
22. Packe GE, Ayres JG. Asthma outbreak during a thunderstorm. Lancet 1985; ii: 199-204.
23. Salvaggio J, Aukrust L. Mold-induced asthma. J Allergy Clin Immunol 1981; 68:327-46.
24. O'Hollaren MT, Yunginger JW, Offord KP et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991; 324:359-63.
25. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320:271-7.
26. Bentley AM, Durham SR, Kay AB. Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. J Invest Allergol Clin Immunol 1994; 4:222-32.
27. Humbert M, Grant JA, Taborda-Barata L et al. High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med 1996; 153: 1931-7.
28. Humbert M, Ying S, Corrigan C et al. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics:relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am J Respir Cell Mol Biol 1997; 16:1-8.
29. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991; 12:256-7.
30. de Vries JE, Gauchat J-F, Aversa G, Punnonen J, Gascan H, Yssel H. Regulation of IgE synthesis by cytokines. Curr Opin Immunol 1992; 3:851-8.
31. Pene J, Rousset F, Briere F et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S a 1988; 85:6880-4.
32. Punnonen J, Aversa G, Cocks BG et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S a 1993; 90:3730-4.
33. Cocks BG, de-Waal-Malefyt R, de Galizzi JP, de Vries JE, Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 1993; 5:657-63.
34. Gascan H, Gauchat JF, Aversa G, Van-Vlasselaer P, de Vries JE. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J Immunol 1991; 147:8-13.
35. Punnonen J, Aversa G, Vanderkerckhove B, Roncarolo M-G, de Vries JE. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells. J Immunol 1992; 148:3398-404.
36. Punnonen J, Aversa G, de Vries JE. Human pre-B cells differentiate into Ig-secreting plasma cells in the presence of interleukin-4 and activated CD4+ T cells or their membranes. Blood 1993; 9:2781-9.
37. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15: 19-26.
38. de-Waal-Malefyt R, Abrams JS, Zurawski SM et al. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 1995; 7:1405-16.
39. Jung T, Wijdenes J, de Neumann C, -Vries JE, Yssel H. Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12. Eur J Immunol 1996; 26:571-7.
40. van-Kooten C, van der Popuw Kraan T, Rensink I, van Oers R, Aarden L. Both naive and memory T cells can provide help for human IgE production, but with different cytokine production requirements. Eur Cytokine Netw 1992; 3:289-97.
41. Armitage RJ, Fanslow WC, Strockbine L et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357:80-2.
42. Clark E, Ledbetter J. How B and T cells talk to each other. Nature 1994; 367:425-8.
43. Bradding P, Feather IH, Howarth PH et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992; 176:1381-6.
44. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
45. Mueller R, Heusser CH, Rihs S, Brunner T, Bullock GR, Dahinden CA. Immunolocalization of intracellular interleukin-4 in normal human peripheral blood basophils. Eur J Immunol 1994; 24:2935-40.
46. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993; 177:605-11.
47. MacGlashan D Jr, White JM, Huang SK, Ono SJ, Schroeder JT, Lichtenstein LM. Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 1994; 152:3006-16.
48. Ochensberger B, Daepp GC, Rihs S, Dahinden CA. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood 1996; 88:3028-37.
49. Kasaian MT, Clay MJ, Happ MP, Garman RD, Hirani S, Luqman M. IL-4 production by allergen-stimulated primary cultures: identification of basophils as the major IL-4-producing cell type. Int Immunol 1996; 8:1287-97.
50. Schroeder JT, Lichtenstein LM, MacDonald SM. An immunoglobulin E-dependent recombinant histamine-releasing factor induces interleukin-4 secretion from human basophils. J Exp Med 1996; 183:1265-70.
51. Schroeder JT, Lichtenstein LM, MacDonald SM. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils. J Immunol 1997; 159:447-52.
52. Gauchat JF, Henchoz S, Mazzei G et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365:340-3.
53. Solomon WR, Burge HA, Muilenberg ML. Allergen carriage by atmospheric aerosol. I. Ragweed pollen determinants in smaller micronic fractions. J Allergy Clin Immunol 1983; 72:443-7.
54. Suphioglu C, Singh MB, Taylor P et al. Mechanism of grass-pollen-induced asthma. Lancet 1992; 339:569-72.
55. Bellomo R, Gigliotti P, Treloar A et al. Two consecutive thunderstorm associated epidemics of asthma in the city of Melbourne. The possible role of rye grass pollen. Med J Aust 1992; 156:834-7.
56. Sotomayor H, Badier M, Vervloet D, Orehek J. Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen. Reversal by corticosteroids. Am Rev Respir Dis 1984; 130:56-8.
57. Bousquet J, Vignola AM, Chanez P, Campbell AM, Bonsignore G, Michel FB. Airways remodelling in asthma:no doubt, no more? Int Arch Allergy Immunol 1995; 107:211-4.
58. Bessot JC, de-Blay F, Pauli G. From allergen sources to reduction of allergen exposure. Eur Respir J 1994; 7:392-7.
59. Durham SR. Allergen avoidance measures. Respir Med 1996; 90:441-5.
60. Vervloet D, Penaud A, Razzouk H et al. Altitude and house dust mites. J Allergy Clin Immunol 1982; 69:290-6.
61. Sensi LG, Piacentini GL, Nobile E et al. Changes in nasal specific IgE to mites after periods of allergen exposure-avoidance: a comparison with serum levels. Clin Exp Allergy 1994; 24:377-82.
62. Simon HU, Grotzer M, Nikolaizik WH, Blaser K, Schoni MH. High altitude climate therapy reduces peripheral blood T lymphocyte activation, eosinophilia, and bronchial obstruction in children with house-dust mite allergic asthma. Pediatr Pulmonol 1994; 17:304-11.
63. Boner A, Peroni D, Piacentini G, Venge P. Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy 1993; 23:1021-6.
64. Platts-Mills TA, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982; ii:675-8.
65. Marks GB, Tovey ER, Green W, Shearer M, Salome CM, Woolcock AJ. The effect of changes in house dust mite allergen exposure on the severity of asthma. Clin Exp Allergy 1995; 25:114-8.
66. Sensi LG, Piacentini GL, Nobile E et al. Changes in nasal specific IgE to mites after periods of allergen exposure-avoidance: a comparison with serum levels. Clin Exp Allergy 1994; 24:377-82.
67. Simon HU, Grotzer M, Nikolaizik WH, Blaser K, Schoni MH. High altitude climate therapy reduces peripheral blood T lymphocyte activation, eosinophilia, and bronchial obstruction in children with house-dust mite allergic asthma. Pediatr Pulmonol 1994; 17:304-11.
68. Boner A, Peroni D, Piacentini G, Venge P. Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy 1993; 23:1021-6.
69. Platts-Mills TA, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982; 2:675-8.
70. Marks GB, Tovey ER, Green W, Shearer M, Salome CM, Woolcock AJ. The effect of changes in house dust mite allergen exposure on the severity of asthma. Clin Exp Allergy 1995; 25:114-8.
71. Carswell F, Birmingham K, Oliver J, Crewes A, Weeks J. The respiratory effects of reduction of mite allergen in the bedrooms of asthmatic children - a double-blind controlled trial. Clin Exp Allergy 1996; 26:386-96.